LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Haralambous, E.; Weiss, H. A.; Radalowicz, A.; Hibberd, M. L.; Booy, R.; Levin, M. (2003)
Publisher: Cambridge University Press
Languages: English
Types: Article
Subjects: Research Article
To quantify the host genetic component of meningococcal disease (MD) susceptibility, the sibling risk ratio (lambdaS) was calculated as the ratio of observed MD cases among 845 siblings of 443 UK Caucasian cases to that expected, calculated from age-calendar year specific rates for England and Wales. Twenty-seven siblings contracted MD compared with an expected 0.89, generating a lambdaS value of 30.3. Overestimation of lambdaS due to Neisseria meningitidis exposure was minimized by excluding siblings with MD onset within set time points of the index case. Irrespective of whether siblings contracted MD more than 1, 3, 6, 9 or 12 months after the index case, the lambdaS varied slightly (lambdaS range: 8.2-11.9), suggesting that host genetic factors may contribute approximately one third of the total lambdaS. Social class distribution did not differ between MD cases and the general population of England and Wales. This study is the first to calculate lambdaS for MD and establishes that susceptibility to MD has a significant host genetic component.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988 ; 318 : 727-32.
    • 2. Comstock GW. Tuberculosis in twins : a re-analysis of the Prophit survey. Am Rev Respir Dis 1978 ; 117 : 621-4.
    • 3. Fine PE. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. Int J Lepr Other Mycobact Dis 1981 ; 49 : 437-54.
    • 4. Jepson AP, Banya WA, Sisay-Joof F, Hassan-King M, Bennett S, Whittle HC. Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J Infect Dis 1995 ; 172 : 316-9.
    • 5. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection : genetic and environmental influences. A study of twins. Ann Intern Med 1994 ; 120 : 982-6.
    • 6. Hill A. The genomics and genetics of human infectious disease susceptibility. Ann Rev Genomics Hum Genet 2001 ; 2 : 373- 400.
    • 7. Kwiatkowski D. Genetic dissection of the molecular pathogenesis of severe infection. Intensive Care Med 2000 ; 26 : S89-97.
    • 8. Greenfield S, Sheehe P, Feldman H. Meningococcal carriage in a population of normal families. J Infect Dis 1971 ; 123 : 67-73.
    • 9. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey : nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987 ; 99 : 591-601.
    • 10. Hibberd M, Sumiya M, Summerfield J, Booy R, Levin M, Group MR. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999 ; 353 : 1049-53.
    • 11. Linton SM, Morgan BP. Properdin deficiency and meningococcal disease-identifying those most at risk. Clin Exp Immunol 1999 ; 118 : 189-91.
    • 12. Spath PJ, Sjoholm AG, Fredrikson GN, et al. Properdin deficiency in a large Swiss family : identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 1999 ; 118 : 278-84.
    • 13. Ross SC, Densen P. Complement deficiency states and infection : epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984 ; 63 : 243-73.
    • 14. Devine LF, Pierce WE, Floyd TM, et al. Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California. Am J Epidemiol 1970 ; 92 : 25-32.
    • 15. Edwards EA, Devine LF, Sengbusch GH, Ward HW. Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 1977 ; 9 : 105-10.
    • 16. Gilmore A, Jones G, Barker M, Soltanpoor N, Stuart JM. Meningococcal disease at the University of Southampton : outbreak investigation. Epidemiol Infect 1999 ; 123 : 185-92.
    • 17. Stephens DS. Uncloaking the meningococcus : dynamics of carriage and disease. Lancet 1999 ; 353 : 941-2.
    • 18. Anderson J, Berthelsen L, Bech Jensen B, Lind I. Dynamics of the meningococcal carrier state and characteristics of the carrier strains : a longitudinal study within three cohorts of military recruits. Epidemiol Infect 1998 ; 121 : 85-94.
    • 19. Neal K, Nguyen-Van-Tan J, Slack R, Kaczmarski E, White A, Ala Aldeen D. Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report. Epidemiol Infect 1999 ; 123 : 507-9.
    • 20. Cartwright K. Meningococcal carriage and disease. In : Cartwright K, ed. Meningococcal disease. London : John Wiley and Sons, 1995 : 115- 46.
    • 21. Achtman M. Global epidemiology of meningococcal disease. In : Cartwright K, ed. Meningococcal disease. Chichester : John Wiley and Sons, 1995 : 159- 77.
    • 22. Aycock W, Mueller J. Meningococcus carrier rates and meningitis incidence. Bact Rev 1950 ; 14 : 115-60.
    • 23. Gold R, Goldschneider I, Lepow M, Draper T, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978 ; 137 : 112-21.
    • 24. Scholten RJ, Bijlmer HA, Tobi H, Dankert J, Bouter LM. Upper respiratory tract infection, heterologous immunisation and meningococcal disease. J Med Microbiol 1999 ; 48 : 943-6.
    • 25. Jha D, Ghosh MK. Epidemiology of meningococcal carrier state amongst recruits of a military training centre. J Commun Dis 1995 ; 27 : 250-5.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article